Wen Leana
- SEC CIK
- 0001847598
In the past year, 2 open-market sale filings worth $331.7K and no purchases.
Current role at each company
- GKOS GLAUKOS CorpDirectoras of Aug 3, 2026
- URGN UroGen Pharma Ltd.Directoras of Jun 24, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $331.7K
- 2 filings
- Net
- −$331.7K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Wen Leana as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
GKOS GLAUKOS Corp
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 3, 2026 (view filing)4:41 PM ET | Jul 31 | 3 days | Wen LeanaDirector | SSale | −525 | $167.63 | −$88.0K | −2.4%21.1K after | |
| May 4, 2026 (view filing) | May 1 | 3 days | Wen LeanaDirector | SSale | −1.70K | $143.35 | −$243.7K | −7.9%19.7K after |